September 2, 2019 / 6:22 AM / 16 days ago

Dechra ramps up contingency plan for a potential hard Brexit

Sept 2 (Reuters) - British veterinary firm Dechra Pharmaceuticals said on Monday it changed the ownership of all UK marketing authorisations to a new unit in the Netherlands, as it prepares for a potential hard Brexit.

The company said it shifted all the analytical testing methods for products made at its site in Skipton, England, to a new lab in Zagreb, Croatia. (Reporting by Justin George Varghese in Bengaluru; Editing by Arun Koyyur)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below